Three-Parent IVF: What's The Hurry?
By John Farrell,
Forbes
| 02. 28. 2015
[Quotes CGS's Marcy Darnovsky]
Untitled Document
With last week’s parliamentary vote, the U.K. is quickly moving ahead with plans to be the first nation to allow germline engineering of children via a controversial method of in-vitro fertilization.
So-called three-parent IVF involves the generation of an embryo using the DNA of three donors: the mother, the father and a donor woman whose egg, or oocyte, will house the nuclear DNA of both parents in order to circumvent the inheritance of rare mitochondrial diseases.
In the normal course of reproduction, all children inherit the mitochondrial DNA of their mothers. Mitochondria are small organelles found in the cytoplasm of the cell outside the nucleus and they contain their own comparatively small component of DNA. Their primary –but by no means only–role is to provide the energy the cell needs. But inherited mutations in some can lead to terrible diseases.
These include conditions such as Kearns–Sayre syndrome, which can lead to progressive blindness and blocked heart. It usually manifests itself before the age of 15. Another is NARP (neurogenic weakness, ataxia and retinitis pigments), also an early onset condition...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...